Clinical Trial Update: Testing Ramipril to Prevent Memory Loss in People With Glioblastoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating ramipril to prevent memory loss in glioblastoma patients undergoing radiotherapy has completed enrollment and posted results. Results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Ramipril (ramipril)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Glioblastoma, Radiotherapy; Complications | Phase 2 | Status: COMPLETED | Results posted: 2026-03-13